High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium
The presence of Pseudomonas aeruginosa biofilms in cystic fibrosis (CF) patients suffering from chronic lung infections contributes to the failure of antimicrobial therapy. Conventionally, the minimal inhibitory concentration (MIC) is determined to assess the antimicrobial susceptibility of a pathog...
Main Authors: | Amber De Bleeckere, Sara Van den Bossche, Pieter-Jan De Sutter, Tine Beirens, Aurélie Crabbé, Tom Coenye |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Biofilm |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590207523000035 |
Similar Items
-
Echinacoside reduces intracellular c-di-GMP levels and potentiates tobramycin activity against Pseudomonas aeruginosa biofilm aggregates
by: Yu-Ming Cai, et al.
Published: (2025-03-01) -
Quantification of Pseudomonas aeruginosa in multispecies biofilms using PMA-qPCR
by: Sarah Tavernier, et al.
Published: (2015-02-01) -
The Antimicrobial Peptide lin-SB056-1 and Its Dendrimeric Derivative Prevent Pseudomonas aeruginosa Biofilm Formation in Physiologically Relevant Models of Chronic Infections
by: Lucia Grassi, et al.
Published: (2019-02-01) -
Developing selective media for quantification of multispecies biofilms following antibiotic treatment.
by: Eva Vandeplassche, et al.
Published: (2017-01-01) -
Pooling isolates to address the diversity in antimicrobial susceptibility of Pseudomonas aeruginosa in cystic fibrosis
by: Sara Van den Bossche, et al.
Published: (2023-12-01)